Adjuvant standard of care treatment with or without trial vaccine for stage I or II adenocarcinoma patients who have had a complete surgical resection.
Treatment must begin within 8 weeks of the resection.
Exclusions include, but are not limited to: Chronic steroid usage, active metastatic disease, autoimmune disease or uncontrolled congestive heart failure or infection.
Clinical Trial #Z5041:
Chemotherapy before and after surgery for adenocarcinoma of the head or uncinate process of the pancreas.
Participants CA 19-9 must be less than 1,000 and weight loss must be below 15% from their pre-disease weight.
Exclusions include, but are not limited to: Visceral or peritoneal metastases, occlusion of the superior mesenteric vein, active infection that is requiring IV antibiotic or evidence of tumor extension to the celiac axis, hepatic artery or superior mesenteric artery.